New paediatric blood test to prevent sudden death from hereditary heart condition
Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
Read More
Tag: Action Medical Research
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
